India's indigenous vaccine Covaxin from Bharat Biotech cleared for phase III trials


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ India's indigenous vaccine Covaxin from Bharat Biotech cleared for phase III trials
Bharat Biotech's Covaxin could be the first vaccine to hit the market

In a huge boost to India's indigenous vaccine plan, Bharat Biotech has been given clearance for phase three trials in India. Covaxin's third phase trials will start in the first week of November.

Under the Phase 3 trial, the vaccine will be administered to 22 thousand people across 19 places. The government aims to vaccinate 20 to 25 crore people between January and July next year.

The government has also sought a list of all those who will be given the vaccine. Initially, the vaccine will be given on a priority basis. It is to be noted that India manufacturers around 60% of vaccine supply worldwide.

The focused efforts of Centre and State/UT governments on effective clinical management of the hospitalized cases have ensured that India’s Fatality Rate has touched 1.5%. Less than 500 deaths (480) have been reported in the last 24 hours in the country. India has one of the lowest fatality rates in the world. The Case Fatality rate is lowest since 22nd March and is continuously declining. 2218 Dedicated COVID Hospitals are providing quality medical care. At the ground level, frontline health workers like ASHAs and ANMs have done a commendable job of managing the migrant population and to enhance awareness at the community level.

As a result, there are 14 States and UTs with CFR lower than 1%.59,105 new recoveries were added in the last 24 hour whereas new recovered cases were 45,148. With this, the total number of recoveries have crossed 71 Lakh (71,37,228). A higher number of single-day recoveries is also reflected in the continuous increase in the national recovery rate, which is at present 90.23%. India continues to report a trend of steadily decreasing active cases.

Presently the active cases comprise merely 8.26% of the total positive cases of the country standing at 6,53,717. This is the lowest since 13th August when the active cases were 6,53,622. 78% of the new recovered cases are observed to be concentrated in 10 States/UTs. Karnataka has contributed the maximum to the single-day recoveries with more than 10,000 cases followed by Kerala with more than 7,000 cases. 45,148 new confirmed cases were registered in the last 24 hours in the country.

This is the lowest since 22nd July when 37,000 new cases were added. 82% of new confirmed cases are from 10 States and UTs. Kerala and Maharashtra contribute maximum to the new confirmed cases with more than 6,000 cases each followed by Karnataka, Delhi and West Bengal with more than 4,000 cases. 480 case fatalities have been reported in the past 24 hours. Of these, nearly 80% are concentrated in ten States/UTs. More than 23% of new fatalities reported are from Maharashtra (112 deaths).

Tags : #Covaxin #BharatBiotech #CovidVaccineNewsOct27 #IndiaCovidNewsOct27 #IndiaCaseFatalityRateOct27

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026